Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Ocular Therapeutix stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OCUL.
You can purchase shares of Ocular Therapeutix (NASDAQ:OCUL) through any online brokerage.
Other companies in Ocular Therapeutix’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Xeris Biopharma Holdings (NASDAQ:XERS) and Tarsus Pharmaceuticals (NASDAQ:TARS).
Ocular Therapeutix has a consensus price target of $16.42.
The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $7.45 last updated March 18, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Ocular Therapeutix.
Ocular Therapeutix’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Ocular Therapeutix.
Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.